📰 Thyroid Disorders News
Page 3 - Thyroid Disorders News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Thyroid Disorders. Real-time updates on events, politics, business and more.
May 26, 2023
The most common thyroid disorder seen among adults in India is hypothyroidism. Read on to know the causes, symptoms and treatment of thyroid disorders. TheHealthSite.com
April 16, 2023
Results presented at AACR 2023 found that four times as many patients treated with Imfinzi plus chemotherapy before surgery achieved pathologic complete response versus those treated with neoadjuvant... | April 16, 2023
April 16, 2023
Results from Phase 3 KEYNOTE-966 to be presented at AACR 2023 Annual Meeting during Clinical Trials Plenary Session, included in official meeting press program and published simultaneously in The... | April 16, 2023
March 17, 2023
Blinded arms of the study will continue to further evaluate MK-7684A with docetaxel versus docetaxel aloneRAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today provided an update on the open-label arm of the non-registrational Phase 2 KeyVibe-002 trial. KeyVibe...
March 13, 2023
Nearly 37 children per 1,000 are believed to have thyroid illness. Here are some signs and symptoms of hypothyroidism parents should look out for in kids. TheHealthSite.com
February 17, 2023
Thyroid disease can affect anyone men, women, infants, teenagers and the elderly. Scroll down to know the causes symptoms and cure
January 22, 2023
Thyroid disorders in children can be managed with medication and lifestyle changes.
November 14, 2022
When dealing with hypothyroidism, some important diet changes should be made. Here are the list of foods on a hypothyroidism diet 2023.
October 29, 2022
Iron is also necessary for vegans. Do the best 2023 vegan iron supplements offered by these five companies satisfy vegans' requirements?
September 12, 2022
HIMALAYA Phase III trial exploratory results support the benefit of tremelimumab added to IMFINZI in unresectable liver cancer regardless of etiology Updated results from the TOPAZ-1 Phase III trial